Abbott Laboratories (ABT)
-NYSE | Prev Close: | 37.48 |
|---|
| Open: | N/A |
|---|
| Bid: | 36.00 x 100 |
|---|
| Ask: | 38.75 x 300 |
|---|
| 1y Target Est: | 39.94 |
|---|
| Beta: | 0.53 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 28.46 - 38.77 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 7,348,490 |
|---|
| Market Cap: | 58.43B |
|---|
| P/E (ttm): | 11.42 |
|---|
| EPS (ttm): | 3.28 |
|---|
| Div & Yield: | 0.56 (1.50%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullbackat Seeking Alpha(Fri, 03:48 SGT)
- Socially Minded Seniors Keep Co-Op Spirit Alive In Cambridgeat Forbes(Thu, 23 May)
- AbbVie Price Boost of Drug Slammed in Studies Criticizedat Bloomberg(Thu, 23 May)
- Va. entrepreneur caught in growing political dramaAP(Tue, 14 May)
- FDA warns pregnant women of migraine drug riskAP(Tue, 7 May)
- AbbVie 1Q earnings top analyst estimatesAP(Sat, 27 Apr)
- Drugmaker AbbVie rises following analyst upgradeAP(Tue, 23 Apr)
- Analysis - Ahead of reform, medical care slowdown hits U.S. companiesReuters(Mon, 22 Apr)
- Big Pharma down, not out, after Novartis patent blowReuters(Tue, 2 Apr)
- Panel proposes to regulate prices of patented medicinesReuters(Tue, 26 Feb)
- FDA Clears Testosterone GelZacks(Thu, 7 Feb)
- Zacks #5 Rank Additions for MondayZacks(Mon, 4 Feb)
- Zacks Industry Outlook Highlights: Johnson & Johnson, Hologic, Abbott Laboratories, AbbVie and Quest DiagnosticsZacks(Wed, 30 Jan)
- Covidien's 1Q Beats, Raises ViewZacks(Sat, 26 Jan)
- Zacks #5 Rank Additions for TuesdayZacks(Tue, 15 Jan)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| ABT | 0.00% | 58.43B |
| ABT.MX |  0.37% | 726.43B |
| SN.L | 0.00% | 7.10B |
| MDT.MX | 4.84% | 653.90B |
Key Statistics
| Forward P/E (1 yr): | 16.66 |
|---|
| P/S (ttm): | 1.46 |
|---|
| Ex-Dividend Date: | 11-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.01 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.44 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.48 |
|---|
Business Summary
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine ins...
View More